Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 3Phase EARLY_PHASE1 2Phase 1/2 2Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Squamous Cell Carcinoma of Head and Neck 2Head and Neck Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

pembrolizumab 4Magnetic Resonance Spectroscopy 4Radiotherapy 3Nivolumab 3Cetuximab 3fluoromisonidazole 2durvalumab 2Neoadjuvant Therapy 2Metformin 2Immunohistochemistry 2Immunoglobulin G 2Fluorodeoxyglucose F18 2Cisplatin 2sitravatinib 1ruxolitinib 1ribociclib 1fluciclovine F-18 1dornase alfa 1avelumab 1antitumor A 1alovudine 1Varenicline 1Valproic Acid 1VTX-2337 1TAK-981 1Surgical Procedures, Operative 1Raltegravir Potassium 1Radiotherapy, Intensity-Modulated 1Plastic Surgery Procedures 1Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Squamous Cell Carcinoma of Head and Neck × Immunohistochemistry × Clear all
NCT00601913 2018-07-05

Erlotinib and Surgery in Treating Patients With Head and Neck Cancer That Can Be Removed by Surgery

Wake Forest University Health Sciences

Phase EARLY_PHASE1 Completed
24 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00757549 2017-10-31

3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx

Mayo Clinic

Phase EARLY_PHASE1 Completed
30 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡